Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomised, 2-way Crossover study to access pharmacokinetics of Finerenone and Drug-Drug interaction with Gemfibrozil in Healthy male subjects

Trial Profile

A Randomised, 2-way Crossover study to access pharmacokinetics of Finerenone and Drug-Drug interaction with Gemfibrozil in Healthy male subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2018

At a glance

  • Drugs Finerenone (Primary) ; Gemfibrozil
  • Indications Chronic heart failure; Diabetic nephropathies; Renal failure
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Bayer
  • Most Recent Events

    • 29 May 2018 New trial record
    • 19 May 2018 Results assessing the absolute bioavailability and pharmacokinetics of Finerenone in four crossover studies in healthy male volunteers, published in the European Journal of Drug Metabolism and Pharmacokinetics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top